Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis

doi:10.5501/wjv.v13.i1.88946

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2505)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1476

Figures (1-2)

202

Tables (1-3)

219

Sum=1981

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

142

Download

297

Sum=439

Mar 25, 2024 (publication date) through Dec 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Virol. Mar 25, 2024; 13(1): 88946
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.88946

Table 2 Summary of effect size of different study variables and outcomes between hepatitis C virus-positive group and hepatitis C virus-negative group

No.	Study variables and/or outcomes	No. of data sets	Total number of patients, n (HCV+/HCV-)	No. of patients (%)		Effect size, OR (95%CI)/MD (95%CI)/HR (95%CI)¹	P value	I², %	Model used
No.	Study variables and/or outcomes	No. of data sets	Total number of patients, n (HCV+/HCV-)	HCV+	HCV-	Effect size, OR (95%CI)/MD (95%CI)/HR (95%CI)¹	P value	I², %	Model used
Demographics and histopathological findings
1	Age, yr	4	349 (159/190)	NA		2.55 (-3.09, 8.20)	0.38	82	RE
2	Male	4	349 (159/190)	101 (63.5)	133 (70.0)	0.74 (0.47, 1.17)	0.20	0	FE
3	ALT, IU/L	2	294 (135/159)	NA		22.20 (13.75, 30.65)	< 0.00001^a	0	FE
4	AST, IU/L	2	294 (135/159)	NA		27.27 (20.20, 34.34)	< 0.00001^a	0	FE
5	Albumin, g/L	2	294 (135/159)	NA		-0.11 (-0.34, 0.12)	0.34	71	RE
6	Bilirubin, umol/L	2	294 (135/159)	NA		-0.07 (-0.33, 0.19)	0.61	84	RE
7	Platelets, 10⁴/mm³	2	294 (135/159)	NA		-1.96 (-5.88, 1.96)	0.33	71	RE
8	Tumor size, cm	3	145 (57/88)	NA		-0.61 (-1.79, 0.57)	0.31	62	RE
9	Multiple tumors	3	311 (142/169)	25 (17.6)	30 (17.8)	1.12 (0.61, 2.06)	0.70	0	FE
10	Cirrhosis	2	294 (135/159)	35 (25.9)	11 (6.9)	5.78 (1.38, 24.14)	0.02^a	69	RE
11	Vascular invasion	3	145 (57/88)	20 (35.1)	36 (40.9)	0.76 (0.37, 1.54)	0.45	0	FE
12	Bile duct invasion	2	294 (135/159)	53 (39.3)	64 (40.3)	0.86 (0.53, 1.39)	0.53	0	FE
13	Lymph node metastases	4	349 (159/190)	41 (25.8)	54 (28.4)	0.85 (0.53, 1.37)	0.51	15	FE
14	Stage 4	3	145 (57/88)	18 (31.6)	37 (42.0)	0.64 (0.32, 1.28)	0.21	0	FE
15	Poorly differentiated	2	273 (127/146)	34 (26.8)	18 (12.3)	2.55 (1.34, 4.82)	0.004^a	0	FE
16	Simultaneous HCC lesions	2	128 (50/78)	13 (26.0)	3 (3.8)	8.31 (2.36, 29.26)	0.001^a	0	FE
Outcomes
17	Overall survival	4	841 (145/696)	NA		2.05 (1.46, 2.88)	<0.0001^a	0	FE

¹Odds ratio and 95% confidence interval (CI) was used for dichotomous outcomes, mean difference and 95%CI was used for continuous outcomes, and hazards ratio and 95%CI was used for time-to-event outcomes.

^aData with statistical significance (P < 0.05).

ALT: Alanine transaminase; AST: Aspartate transaminase; CI: Confidence interval; FE: Fixed-effects; HCV: Hepatitis C virus; HR: Hazards ratio; I²: Heterogeneity; MD: Mean difference; NA: Not applicable; OR: Odds ratio; RE: Random-effects.

Citation: Cheo FY, Chan KS, Shelat VG. Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. World J Virol 2024; 13(1): 88946
URL: https://www.wjgnet.com/2220-3249/full/v13/i1/88946.htm
DOI: https://dx.doi.org/10.5501/wjv.v13.i1.88946